While the percentages of CD25- or CD69-expressing iNKT or Vδ2+ T cells did not differ between cohorts upon stimulation with either stimulus (i.e., PMA/ionomycin and α-GC or BrHPP, respectively), we observed an enhanced expression of CD69 on the surface of 5-A-RU-stimulated MAIT cells from obese and obese/T2D patients, compared to controls (Figures 2A–C). The gene discussed is CD69; the disease is type 2 diabetes mellitus.